The American journal of clinical nutrition最新文献_第6页

Introduction to Human Nutrition, edited by Michael J Gibney, Hester H Vorster, and Frans J Kok, 2002, 342 pages, paperback, $49.99. Blackwell Science Ltd, Oxford, United Kingdom. 《人类营养导论》，迈克尔·J·吉布尼、赫斯特·H·沃斯特和弗兰斯·J·科克主编，2002年，342页，平装本，49.99美元。Blackwell科学有限公司，牛津，英国

The American journal of clinical nutrition Pub Date : 2003-12-01 DOI: 10.1093/AJCN/78.6.1228

J. Gilchrist

引用次数: 0

Reply to B Sreedhar 回复B Sreedhar

The American journal of clinical nutrition Pub Date : 2003-12-01 DOI: 10.1093/AJCN/78.6.1226

T. Lind, L. Persson, B. Lönnerdal

引用次数: 3

Reply to RP Heaney 回复RP Heaney

The American journal of clinical nutrition Pub Date : 2003-09-01 DOI: 10.1093/AJCN/78.3.493A

R. Wood, L. Martini

引用次数: 4

Serum 25-hydroxyvitamin D response to oral vitamin D intake in children. 儿童口服维生素D对血清25-羟基维生素D的影响。

The American journal of clinical nutrition Pub Date : 2003-09-01 DOI: 10.1093/AJCN/78.3.496A

A. Zittermann

引用次数: 14

The Nutrition Transition: Diet and Disease in the Developing World edited by Benjamin Caballero and Barry M Popkin, 2002, 276 pages, hardcover, $79.95. Academic Press, London. 《营养转型:发展中国家的饮食与疾病》，本杰明·卡巴列罗和巴里·波普金主编，2002年，276页，精装版，79.95美元。学术出版社，伦敦。

The American journal of clinical nutrition Pub Date : 2003-09-01 DOI: 10.1093/AJCN/78.3.500

N. Solomons, C. Nieves

引用次数: 1

Advances in Nutritional Research, Vol 10, Immunological Properties of Milk, edited by Bill Woodward and Harold H Draper, 2001, 410 pages, hardcover, $140. Kluwer Academic/Plenum Publishers, New York. 营养研究进展，第10卷，牛奶的免疫学特性，比尔·伍德沃德和哈罗德·H·德雷珀编辑，2001年，410页，精装版，140美元。Kluwer学术/全会出版社，纽约。

The American journal of clinical nutrition Pub Date : 2003-03-01 DOI: 10.1093/AJCN/77.3.755

W. Heird

引用次数: 1

Reply to R Cooper and A Luke 回复R Cooper和A Luke

The American journal of clinical nutrition Pub Date : 2003-03-01 DOI: 10.1093/AJCN/77.3.752

N. Schonfeld-Warden, C. Warden

引用次数: 0

Advances in Nutritional Research, Vol 10, Immunological Properties of Milk 营养研究进展，第10卷，牛奶的免疫特性

The American journal of clinical nutrition Pub Date : 2003-03-01 DOI: 10.1093/AJCN/77.3.755B

W. Heird

引用次数: 0

Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. s -腺苷- l-蛋氨酸在抑郁症治疗中的作用:证据综述。

The American journal of clinical nutrition Pub Date : 2002-11-01 DOI: 10.1093/AJCN/76.5.1158S

D. Mischoulon, M. Fava

{"title":"Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.","authors":"D. Mischoulon, M. Fava","doi":"10.1093/AJCN/76.5.1158S","DOIUrl":"https://doi.org/10.1093/AJCN/76.5.1158S","url":null,"abstract":"Major depression remains difficult to treat, despite the wide array of registered antidepressants available. In recent years there has been a surge in the popularity of natural or alternative medications. Despite this growing popularity, there is limited evidence for the effectiveness of many of these natural treatments. S-adenosyl-L-methionine (SAMe) is one of the better studied of the natural remedies. SAMe is a methyl donor and is involved in the synthesis of various neurotransmitters in the brain. Derived from the amino acid L-methionine through a metabolic pathway called the one-carbon cycle, SAMe has been postulated to have antidepressant properties. A small number of clinical trials with parenteral or oral SAMe have shown that, at doses of 200-1600 mg/d, SAMe is superior to placebo and is as effective as tricyclic antidepressants in alleviating depression, although some individuals may require higher doses. SAMe may have a faster onset of action than do conventional antidepressants and may potentiate the effect of tricyclic antidepressants. SAMe may also protect against the deleterious effects of Alzheimer disease. SAMe is well tolerated and relatively free of adverse effects, although some cases of mania have been reported in bipolar patients. Overall, SAMe appears to be safe and effective in the treatment of depression, but more research is needed to determine optimal doses. Head-to-head comparisons with newer antidepressants should help to clarify SAMe's place in the psychopharmacologic armamentarium.","PeriodicalId":315016,"journal":{"name":"The American journal of clinical nutrition","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124578074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 265

Electrophysiological neuroimaging of the central effects of S-adenosyl-l-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography s -腺苷-l-蛋氨酸中枢效应的电生理神经成像，通过脑电图和事件相关电位和低分辨率脑电磁断层成像

The American journal of clinical nutrition Pub Date : 2002-11-01 DOI: 10.1093/AJCN/76/5.1162S

B. Saletu, P. Anderer, C. Padova, A. Assandri, G. Saletu-Zyhlarz

{"title":"Electrophysiological neuroimaging of the central effects of S-adenosyl-l-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography","authors":"B. Saletu, P. Anderer, C. Padova, A. Assandri, G. Saletu-Zyhlarz","doi":"10.1093/AJCN/76/5.1162S","DOIUrl":"https://doi.org/10.1093/AJCN/76/5.1162S","url":null,"abstract":"Background: S-Adenosyl-L-methionine (SAMe, or ademetionine) is a naturally occurring molecule used as both a nutraceutical and a pharmaceutical to treat depression. Objective: The central mode of action of SAMe was investigated in 20 healthy volunteers by mapping of electroencephalograms (EEGs) and event-related potentials (ERPs) and low-resolution brain electromagnetic tomography (LORETA). Design: In an acute and subacute, double-blind, placebo-controlled, crossover study, subjects received in random order infusions of 800 mg SAMe and placebo for 7 d, with a washout period of 3 wk between the 2 treatment periods. EEG recordings were made 0, 1, 3, and 6 h after and ERP recordings were made 0 and I h after the drug infusions on days 1 and 7. Results: Multivariate analyses of variance and Hotelling T 2 tests showed significant acute and subacute encephalotropic effects of SAMe compared with placebo. Acute pharmaco-EEG changes were typical of classic antidepressants of the thymoleptic type; subacute alterations were typical of congnition enhancers. Regarding ERPs, standard N I and P2 latencies were shortened, and target P300 latencies were lengthened. Nl amplitudes increased after subacute treatment, and temporooccipital P300 amplitudes increased after the acute dose Similar changes were described for antidepressants. LORETA showed that the N2 source strength increased in both the left and the right temporal lobes, whereas the P300 source strength increased in the dorsolateral prefrontal regions and decreased in the ventral limbic regions Conclusion: EEG-ERP mapping identified SAMe as an antidepressant. LORETA targeted brain regions crucial in the therapeutic efficacy of antidepressants.","PeriodicalId":315016,"journal":{"name":"The American journal of clinical nutrition","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2002-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127245779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 13